Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

REDX.L (REDX) Regulatory News

Date Source Headline
31st Jul 2017 7:00 am RNS Disposal of BTK inhibitor drug development program
23rd Jun 2017 2:38 pm RNS MHRA approval of Clinical Trial Application
22nd Jun 2017 7:00 am RNS Update on Suspension of Trading
24th May 2017 6:35 pm RNS Statement re. Suspension
24th May 2017 4:35 pm RNS Suspension - Redx Pharma plc
17th May 2017 7:00 am RNS Interim results for six months ended 31 March 2017
15th May 2017 7:00 am RNS Preclinical efficacy data presented on RXC005
4th May 2017 7:00 am RNS Notice of Interim Results
20th Apr 2017 11:20 am RNS Result of AGM
20th Apr 2017 7:00 am RNS Appointment of Chairman
7th Apr 2017 3:56 pm RNS Notice of Annual General Meeting
3rd Apr 2017 7:15 am RNS Hardman: CARB-X - new strategic collaboration
30th Mar 2017 4:03 pm RNS Redx Pharma awarded US$1 million grant by CARB-X
21st Mar 2017 9:05 am RNS Final Results Year Ended 30 September 2016
7th Mar 2017 4:33 pm RNS Holding(s) in Company
3rd Mar 2017 2:35 pm RNS Holding(s) in Company
3rd Mar 2017 2:27 pm RNS Holding(s) in Company
3rd Mar 2017 2:17 pm RNS Holding(s) in Company
2nd Mar 2017 5:01 pm RNS Holding(s) in Company
2nd Mar 2017 7:50 am RNS Redx presentations at AACR 2017
28th Feb 2017 10:35 am RNS Result of General Meeting and Issue of Equity
27th Feb 2017 5:50 pm RNS Result of Open Offer
10th Feb 2017 1:00 pm RNS Result of Placing
9th Feb 2017 7:00 am RNS Accelerated Book Build
8th Feb 2017 6:30 pm RNS Accelerated Book Build
27th Jan 2017 7:00 am RNS Growing opportunity for Porcupine inhibitors
6th Dec 2016 7:00 am RNS Reversible BTK poster at ASH meeting
30th Nov 2016 7:00 am RNS RXC004 pre-clinical profile
16th Nov 2016 3:22 pm RNS Holding(s) in Company
4th Nov 2016 7:00 am RNS Reversible BTK data at ASH meeting
20th Oct 2016 7:00 am RNS Development candidate chosen for leukaemia program
11th Oct 2016 9:32 am RNS Exercise of Options and Total Voting Rights
27th Sep 2016 7:00 am RNS Discovery of breakthrough antibiotic compounds
23rd Sep 2016 4:07 pm RNS Holding(s) in Company
21st Sep 2016 8:50 am RNS Holding(s) in Company
19th Sep 2016 7:00 am RNS Re: Porcupine inhibitor and cancer immunotherapy
16th Sep 2016 11:31 am RNS Holding(s) in Company
14th Sep 2016 10:47 am RNS Holding(s) in Company
8th Sep 2016 7:00 am RNS Board & Senior Management Changes
6th Sep 2016 7:00 am RNS Supply agreement for expected clinical trial
FTSE 100 Latest
Value8,809.74
Change53.53